Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 5mg	5mg	Tablet, dispersible	2,607,054 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 5mg	5mg	Tablet, dispersible	2,607,054 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 10mg	10mg	Tablet, dispersible	5,214,109 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 10mg	10mg	Tablet, dispersible	5,214,109 L.L
L01EC01	ZELBORAF	B	Vemurafenib - 240mg	240mg	Tablet, film coated	L.L
N05AH03	ZYPREXA	B	Olanzapine - 10mg	10mg	Tablet	1,468,820 L.L
N05AH03	ZYPREXA	B	Olanzapine - 10mg	10mg	Tablet	1,468,820 L.L
A04AA01	ZOFRAN	B	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	6,329,648 L.L
A04AA01	ZOFRAN INJECTION	B	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	7,280,806 L.L
J01DD52	ZAVICEFTA	B	Ceftazidime - 2g, Avibactam - 0.5g		Injectable powder for concentrate for solution	101,659,975 L.L
A04AA01	ZOFRAN INJECTION	B	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	9,752,244 L.L
M04AA01	ZYLORIC	B	Allopurinol - 100mg	100mg	Tablet	278,175 L.L
J05AB01	ZOVIRAX IV	B	Aciclovir - 250mg	250mg	Injectable freeze dried substance	2,146,116 L.L
M04AA01	ZYLORIC	B	Allopurinol - 300mg	300mg	Tablet	302,365 L.L
J05AB01	ZOVIRAX	B	Aciclovir - 200mg/5ml	200mg/5ml	Suspension	487,815 L.L
C10AA01	ZOCOR	B	Simvastatin - 10mg	10mg	Tablet	881,817 L.L
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 5mg	5mg	Tablet	295,645 L.L
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 10mg	10mg	Tablet	592,635 L.L
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 20mg	20mg	Tablet	636,981 L.L
C10AA01	ZOCOR	B	Simvastatin - 20mg	20mg	Tablet	976,526 L.L
C10AA01	ZOCOR	B	Simvastatin - 40mg	40mg	Tablet	1,435,992 L.L
J01DI01	ZEVTERA	B	Ceftobiprole medocaril Sodium - 500mg	500mg	Injectable powder for concentrate for solution	47,129,773 L.L
J01DI54	ZERBAXA	B	Ceftolozane Sulfate - 1g, Tazobactam (sodium) - 0.5g		Injectable powder for concentrate for solution	74,780,802 L.L
L01DB06	ZAVEDOS	B	Idarubicin HCl - 10mg	10mg	Injectable freeze dried material	12,071,013 L.L
M05BA08	ZOMETA	B	Zoledronic acid (monohydrate) - 4mg/5ml	4mg/5ml	Injectable concentrated solution	13,697,658 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	35,658,713 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	35,658,713 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L03AA02	ZARZIO	BioTech	Filgrastim - 300mcg/0.5ml	30MU/0.5ml	Injectable solution	13,053,190 L.L